PIM
ACOR

Partner Investment Management’s Acorda Therapeutics ACOR Stock Holding History

Partner Investment Management’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$37K Sell
153
-13
-8% -$3.28K 0.27% 40
2019
Q3 		$57K Buy
+166
New +$90.2K 0.1% 63
2019
Q1 		– Sell
-109
Closed -$204K – 117
2018
Q4 		$204K Sell
109
-20
-16% -$43.5K 0.25% 67
2018
Q3 		$305K Sell
129
-102
-44% -$316K 0.23% 87
2018
Q2 		$795K Sell
231
-155
-40% -$475K 0.64% 61
2018
Q1 		$1.1M Sell
386
-59
-13% -$177K 1.18% 37
2017
Q4 		$1.15M Sell
445
-54
-11% -$154K 1.32% 34
2017
Q3 		$1.42M Buy
499
+101
+25% +$266K 1.34% 28
2017
Q2 		$941K Buy
+398
New +$788K 1.26% 30
2016
Q2 		– Sell
-93
Closed -$296K – 104
2016
Q1 		$296K Sell
93
-140
-60% -$581K 0.48% 56
2015
Q4 		$1.2M Buy
233
+49
+27% +$214K 1.96% 21
2015
Q3 		$587K Buy
184
+22
+14% +$85.3K 0.89% 40
2015
Q2 		$650K Buy
162
+65
+67% +$251K 0.91% 44
2015
Q1 		$386K Sell
97
-163
-63% -$747K 0.58% 60
2014
Q4 		$1.27M Buy
260
+26
+11% +$112K 0.52% 47
2014
Q3 		$950K Buy
+234
New +$878K 0.35% 34
2014
Q2 		– Sell
-237
Closed -$1.08M – 83
2014
Q1 		$1.08M Buy
+237
New +$958K 0.2% 51

Other funds holding ACOR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Partner Investment Management's ACOR Position: Q4 2019 in Review

Partner Investment Management reduced its Acorda Therapeutics (ACOR) stake by 7.8% in Q4 2019, selling an estimated $3.28K and leaving 153 shares worth $37K. The position accounts for 0.27% of the portfolio, ranked #40.

Partner Investment Management first reported a position in ACOR in Q1 2014 and has held it in 17 quarters since. The position peaked at $1.42M in Q3 2017. 121 funds tracked by Wall St. Rank hold ACOR as of Q4 2019.

  • Partner Investment Management held 153 shares of Acorda Therapeutics worth $37K as of Q4 2019.
  • Partner Investment Management sold 13 Acorda Therapeutics shares in Q4 2019, an estimated $3.28K.
  • Acorda Therapeutics made up 0.27% of Partner Investment Management's portfolio in Q4 2019, its #40 holding.
  • Partner Investment Management first reported a position in Acorda Therapeutics in Q1 2014 and has held it in 17 quarters since.
  • Partner Investment Management's Acorda Therapeutics position peaked at $1.42M in Q3 2017.
  • 121 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2019.

Based on Partner Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.